ArticleFrontiers in psychiatry2025
The impact of cancer information overload on negative emotions in newly diagnosed lung cancer patients: the mediating role of fear of progression and the moderating role of social support.
Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Association between information overload, asthenopia, and depressive and anxiety symptoms in patients with lung cancer: A computer-simulated network analysis.Asia-Pacific journal of oncology nursing · 2026Article
- Factors influencing information overload among breast cancer patients in the information explosion era: a cross-sectional study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The high incidence of negative emotions among lung cancer patients has become a significant challenge to global public health. Newly diagnosed patients may experience cancer information overload (CIO) when exposed to a large amount of uncertain cancer-related information within a short time. However, research on the relationship between CIO and negative emotions, and the roles of Fear of Progression (FoP) and social support, is still lacking. Objective: To explore the mediating effect of FoP between CIO and negative emotion in newly diagnosed lung cancer patients, and the moderating role of social support among CIO, FoP and negative emotion. Method: This study adopted a cross-sectional survey design. From October 2024 to February 2025, newly diagnosed lung cancer patients were recruited as research subjects from the oncology departments of three tertiary hospitals in Deyang City, China. Through the General Information Questionnaire, Cancer Information Overload Scale (CIOS), Fear of Progression Questionnaire-Short Form (FoP-Q-SF), Hospital Anxiety and Depression Scale (HADS) and the Social Support Rating Scale (SSRS) were used to investigate patients' CIO, FoP, negative emotions and social support, and a total of 358 valid questionnaires were retrieved. All data were processed using SPSS 26.0, and the mediating effect and moderating effect were tested using the Process plugin. Results: The incidence of anxiety was 56.1% (201/358), and the incidence of depression was 53.1% (190/358). CIO had a positive predictive effect on FoP (β=0.338, Conclusion: Patients with newly diagnosed lung cancer bear a heavy burden of anxiety and depression, which urgently needs attention. CIO plays a mediating role between FoP and negative emotion. Social support weakens the positive predictive effect of FoP on negative emotion. Our research results provide new insights and methods for supporting the improvement of negative emotions in lung cancer patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.